The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc. a firm fixed-price delivery order contract worth $6,638.84 for the supply of 4566692441 PHOTREXA CROSS-LINKING KIT 6ML, a specialized pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group, a woman-owned small business, to leverage its status to secure this direct federal award. This contract award demonstrates DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain, providing a diverse array of prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.
Generated 3/5/25, 9:42 AM